Financial barriers to immunotherapy: challenges and potential mitigation strategies: a review paper.

Key Points

• The central aim is to examine financial obstacles to immunotherapy and propose strategies to address them.
• Review existing literature on financial barriers to immunotherapy.
• Analyze dose-optimization strategies and their impact on costs and efficacy.
• Evaluate potential for international collaborations in research.
• Cost-reduction is possible through dose-optimization without losing clinical effectiveness.
• Validated reduced dosing can improve access to immunotherapy.
• International partnerships may enhance research efforts in low- and middle-income countries (LMICs).